Drug Information

Drug General Information
Drug ID
D05GZI
Former ID
DNC014509
Drug Name
N-(4-Ethylphenyl)benzo[d]oxazol-2-amine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [531178]
Structure
Download
2D MOL

3D MOL
Formula
C15H14N2O
Canonical SMILES
CCC1=CC=C(C=C1)NC2=NC3=CC=CC=C3O2
InChI
1S/C15H14N2O/c1-2-11-7-9-12(10-8-11)16-15-17-13-5-3-4-6-14(13)18-15/h3-10H,2H2,1H3,(H,16,17)
InChIKey
KKIDKWUGBUWNPR-UHFFFAOYSA-N
PubChem Compound ID
39918957
Target and Pathway
Target(s) Arachidonate 5-lipoxygenase Target Info Inhibitor [531178]
BioCyc Pathway Aspirin-triggered lipoxin biosynthesis
Resolvin D biosynthesis
Leukotriene biosynthesis
Lipoxin biosynthesis
Aspirin triggered resolvin D biosynthesis
Aspirin triggered resolvin E biosynthesis
KEGG Pathway Arachidonic acid metabolism
Metabolic pathways
Serotonergic synapse
Ovarian steroidogenesis
Toxoplasmosis
NetPath Pathway IL4 Signaling Pathway
PathWhiz Pathway Arachidonic Acid Metabolism
WikiPathways Vitamin D Receptor Pathway
Arachidonic acid metabolism
Eicosanoid Synthesis
Selenium Micronutrient Network
References
Ref 531178Bioorg Med Chem. 2010 Nov 1;18(21):7580-5. Epub 2010 Oct 1.Synthesis and evaluation of benzoxazole derivatives as 5-lipoxygenase inhibitors.
Ref 531178Bioorg Med Chem. 2010 Nov 1;18(21):7580-5. Epub 2010 Oct 1.Synthesis and evaluation of benzoxazole derivatives as 5-lipoxygenase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.